Comparison of localized high-dose UVA1 irradiation versus topical cream psoralen-UVA for treatment of chronic vesicular dyshidrotic eczema

Journal of the American Academy of Dermatology

Volumn 50, Issue 1, 2004, Pages 68-72

  Petering, Holger ^a   Breuer, Christine ^b   Herbst, Rudolf ^b   Kapp, Alexander ^b   Werfel, Thomas ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHOXSALEN; PSORALEN DERIVATIVE;

ADULT; AGED; ARTICLE; CHRONIC VESICULAR DYSHIDROTIC ECZEMA; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MALE; POMPHOLYX; PRIORITY JOURNAL; PUVA; SCORING SYSTEM; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION;

EID: 0347003661     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(03)00782-5     Document Type: Article

References (21)

1. De Rie MA, Van Eendenburg JP, Versnick AC, Stolk LM, Bos JD, Westerhof W. A new psoralen-containing gel for topical PUVA therapy: development, and treatment results in patients with palmoplantar and plaque-type psoriasis, and hyperkeratotic eczema. Br J Dermatol 1995;136:964-9.
2. Stege H, Berneburg M, Ruzicka T, Krutmann J. Cream PUVA photochemotherapy. Hautarzt 1997;48:89-3.
3. Degitz K, Plewig G, Röcken M. Rapid decline in photosensitivity after 8-methoxypsoralen bathwater delivery. Arch Dermatol 1996;132:1394-5.
4. Grundmann-Kollmann M, Tegeder I, Ochsendorf FR, Zollner TM, Ludwig R, Kaufmann R, et al. Kinetics and dose-response of photosensitivity in cream psoralen plus ultraviolet A photochemotherapy: comparative in vivo studies after topical application of three standard preparations. Br J Dermatol 2001; 144:991-5.
5. Kerscher M, Gruss C, von Kobyletzki G, Volkenandt M, Neumann NJ, Altmeyer P, et al. Time course of 8-MOP-induced skin photosensitization in PUVA bath photochemotherapy. Br J Dermatol 1997;136:473-4.
6. Grundmann-Kollmann M, Behrens S, Peter RU, Kerscher M. Treatment of severe recalcitrant dermatoses of the palms and soles with PUVA-bath versus PUVA-cream therapy. Photodermatol Photoimmunol Photomed 1999;15:87-9.
7. Petrozzi JW, Kaidbey KM, Kligman AM. Topical methoxsalen and blacklight in the treatment of psoriasis. Arch Dermatol 1977; 113:292-6.
8. Vocks E, Plotz SG, Ring J. The Dyshidrotic Eczema Area and Severity Index-a score developed for the assessment of dyshidrotic eczema. Dermatology 1999;198:265-9.
9. Krutmann J, Diepgen TL, Luger TA, Grabbe S, Meffert H, Sonnichsen N, et al. High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial. J Am Acad Dermatol 1998;38: 589-3.
10. Schmidt T, Abeck D, Boeck K, Mempel M, Ring J. UVA1 irradiation is effective in treatment of chronic vesicular dyshidrotic hand eczema. Acta Derm Venereol 1998;78:318-9.
11. Odia S, Vocks E, Rakoski J, Ring J. Successful treatment of dyshidrotic hand eczema using tap water iontophoresis with pulsed direct current. Acta Derm Venereol 1996;76:472-4.
12. Behrens-Williams S, Gruss C, Grundmann-Kollmann M, Peter RU, Kerscher M. Assessment of minimal phototoxic dose following 8-methoxypsoralen bath: maximal reaction on average after 5 days. Br J Dermatol 2000;142:112-5.
13. Ibbotson SH, Farr PM. The time-course of psoralen ultraviolet A (PUVA) erythema. J Invest Dermatol 1999;113:346-50.
14. Stern RS, Nichols KT, Vakeva LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA): the PUVA follow-up study. N Engl J Med 1997;336:1041-5.
15. Stern RS, Lunder EJ. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA): a meta-analysis. Arch Dermatol 1998;134:1582-5.
16. Godar DE. Preprogrammed and programmed cell death mechanisms of apoptosis: UV-induced immediate and delayed apoptosis. Photochem Photobiol 1996;63:825-30.
17. Godar DE. UVA1 radiation triggers two different final apoptotic pathways. J Invest Dermatol 1999;112:3-12.
18. Morita A, Werfel T, Stege H, Ahrens C, Karmann K, Grewe M, et al. Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J Exp Med 1997;186:1763-8.
19. Grabbe J, Welker P, Humke S, Grewe M, Schopf E, Henz BM, et al. High-dose ultraviolet A1 (UVA1), but not UVA/UVB therapy, decreases IgE-binding cells in lesional skin of patients with atopic eczema. J Invest Dermatol 1996;107:419-22.
20. Anderson RR. Tissue optics and photoimmunology. In: Parrish JA, editor. Photoimmunology. New York: Plenum Medical, 1983. p. 73.
21. Bruls WA, Slaper H, van der Leun JC, Berrens L. Transmission of human epidermis and stratum corneum as a function of thickness in the ultraviolet and visible wavelengths. Photochem Photobiol 1984;40:485-94.